Microplasmin study shows promising results for two serious eye conditions
Tuesday, June 8, 2010 - 18:00
in Health & Medicine
A Phase III trial of a drug used for the treatment of vitreomacular adhesion (VMA) and macular hole (MH) revealed key findings for patients diagnosed with these severe conditions which can lead to significant vision impairment.